Retinal Vessel Pulsatile Characteristics Associated With Vascular Stiffness Can Predict the Rate of Functional Progression in Glaucoma Suspects.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
medline:
21
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
Tissue stiffening and alterations in retinal blood flow have both been suggested as causative mechanisms of glaucomatous damage. We tested the hypothesis that retinal blood vessels also stiffen, using laser speckle flowgraphy (LSFG) to characterize vascular resistance. In the longitudinal Portland Progression Project, 231 eyes of 124 subjects received LSFG scans of the optic nerve head (ONH) and automated perimetry every 6 months for six visits. Eyes were classified as either "glaucoma suspect" or "glaucoma" eyes based on the presence of functional loss on the first visit. Vascular resistance was quantified using the mean values of several instrument-defined parameterizations of the pulsatile waveform measured by LSFG, either in major vessels within the ONH (serving the retina) or in capillaries within ONH tissue, and age-adjusted using a separate group of 127 healthy eyes of 63 individuals. Parameters were compared against the severity and rate of change of functional loss using mean deviation (MD) over the six visits, within the two groups. Among 118 "glaucoma suspect" eyes (average MD, -0.4 dB; rate, -0.45 dB/y), higher vascular resistance was related to faster functional loss, but not current severity of loss. Parameters measured in major vessels were stronger predictors of rate than parameters measured in tissue. Among 113 "glaucoma" eyes (average MD, -4.3 dB; rate, -0.53 dB/y), higher vascular resistance was related to more severe current loss but not rate of loss. Higher retinal vascular resistance and, by likely implication, stiffer retinal vessels were associated with more rapid functional loss in eyes without significant existing loss at baseline.
Identifiants
pubmed: 37335567
pii: 2785711
doi: 10.1167/iovs.64.7.30
pmc: PMC10284309
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Subventions
Organisme : NEI NIH HHS
ID : R01 EY020922
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031686
Pays : United States
Références
Proc SPIE Int Soc Opt Eng. 2017 Feb;10067:
pubmed: 29618852
Am J Physiol Cell Physiol. 2020 Oct 1;319(4):C611-C623
pubmed: 32667866
Ophthalmologica. 1996;210(5):257-62
pubmed: 8878207
Acta Ophthalmol. 2010 Nov;88(7):723-9
pubmed: 19725814
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4189-99
pubmed: 16249498
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):540-6
pubmed: 15671280
Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4271-7
pubmed: 23737471
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3598-604
pubmed: 22570353
Ophthalmology. 2016 Jun;123(6):1173-80
pubmed: 26949119
Clin Ophthalmol. 2008 Dec;2(4):849-61
pubmed: 19668439
Invest Ophthalmol Vis Sci. 2014 May 08;55(6):3509-16
pubmed: 24812551
Arch Ophthalmol. 2012 Dec;130(12):1541-6
pubmed: 23229692
Transl Vis Sci Technol. 2020 Dec 06;9(11):4
pubmed: 33288991
Proc Natl Acad Sci U S A. 2022 Feb 15;119(7):
pubmed: 35135877
PLoS One. 2016 Dec 13;11(12):e0168190
pubmed: 27959905
Acta Biomater. 2021 Oct 15;134:379-387
pubmed: 34274532
Clin Ophthalmol. 2011;5:1549-56
pubmed: 22125400
Transl Vis Sci Technol. 2021 Jan 07;10(1):13
pubmed: 33510952
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2201-4
pubmed: 10892863
Clin Ophthalmol. 2011;5:1171-6
pubmed: 21887100
Am J Ophthalmol. 2001 Jul;132(1):63-9
pubmed: 11438055
Arch Ophthalmol. 1992 Jun;110(6):812-9
pubmed: 1596230
Rev Prat. 1975 Dec 21;25(59):4671-80
pubmed: 1215793
Am J Ophthalmol. 2008 Sep;146(3):466-472
pubmed: 18571616
J Clin Med. 2022 Oct 13;11(20):
pubmed: 36294371
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3110-3118
pubmed: 31323681
Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1767-80
pubmed: 23404116
Ophthalmology. 2007 Nov;114(11):1965-72
pubmed: 17628686
Am J Ophthalmol. 2016 Oct;170:75-82
pubmed: 27491698
Radiology. 1999 May;211(2):411-7
pubmed: 10228522
Sci Rep. 2018 Mar 28;8(1):5343
pubmed: 29593269
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3662-8
pubmed: 15452074
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):10
pubmed: 34994770
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO180-BIO190
pubmed: 28715580
Curr Eye Res. 2016 Nov;41(11):1447-1453
pubmed: 27159148
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5083-91
pubmed: 20484598
Optom Vis Sci. 2008 Jun;85(6):425-35
pubmed: 18521012
Opt Lett. 2015 Oct 15;40(20):4771-4
pubmed: 26469616
Sci Rep. 2021 Oct 8;11(1):20034
pubmed: 34625616
Invest Ophthalmol Vis Sci. 2014 Nov 11;55(12):8163-72
pubmed: 25389203
Am J Ophthalmol. 2022 Jan;233:180-188
pubmed: 34283973
BMC Ophthalmol. 2021 Aug 21;21(1):303
pubmed: 34416871
J Hypertens. 2015 Jul;33(7):1446-51
pubmed: 26039533
Sci Rep. 2018 Aug 23;8(1):12639
pubmed: 30140057
Am J Ophthalmol. 2001 Jun;131(6):699-708
pubmed: 11384564
Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):9023-32
pubmed: 21989723
Am J Ophthalmol. 2003 Dec;136(6):1022-31
pubmed: 14644212
EPMA J. 2014 Jul 08;5(1):11
pubmed: 25075228
Surv Ophthalmol. 2018 Jan - Feb;63(1):56-74
pubmed: 28666629
Biomech Model Mechanobiol. 2014 Jun;13(3):551-63
pubmed: 23896936
Exp Eye Res. 2017 May;158:3-12
pubmed: 27448987
Acta Ophthalmol Scand. 1997 Aug;75(4):368-75
pubmed: 9374242
J Biophotonics. 2018 Feb;11(2):
pubmed: 29024538
Prog Retin Eye Res. 1998 Apr;17(2):267-89
pubmed: 9695795
Ophthalmology. 2017 Nov;124(11):1612-1620
pubmed: 28676280
Arch Ophthalmol. 1998 Nov;116(11):1491-5
pubmed: 9823351
Am J Ophthalmol. 2014 May;157(5):945-52
pubmed: 24513094
Vision Res. 2011 Aug 15;51(16):1801-10
pubmed: 21704057
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):99-105
pubmed: 27743161
Ophthalmology. 2018 Jan;125(1):15-21
pubmed: 28863943
Exp Eye Res. 2009 Apr;88(4):799-807
pubmed: 19217902
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1774-82
pubmed: 10845598
Prog Retin Eye Res. 2007 Nov;26(6):688-710
pubmed: 17889587
Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8303-9
pubmed: 23169886
Prog Retin Eye Res. 2016 Nov;55:82-107
pubmed: 27417037
Prog Retin Eye Res. 2002 Jul;21(4):359-93
pubmed: 12150988
J Glaucoma. 2004 Aug;13(4):340-4
pubmed: 15226664